Nissan Chemical Dirección

Dirección controles de criterios 2/4

El CEO de Nissan Chemical's es Kojiro Kinoshita, nombrado en Jan 2008, tiene una permanencia de 16.25 años. posee directamente un 0.071% de las acciones de la empresa, con un valor de ¥538.80M. La antigüedad media del equipo directivo y de la junta directiva es de 4 años y 3.3 años, respectivamente.

Información clave

Kojiro Kinoshita

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	16.5yrs
Participación del CEO	0.07%
Permanencia media de la dirección	3.9yrs
Promedio de permanencia en la Junta Directiva	3.6yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Kojiro Kinoshita (76 yo)

16.5yrs

Permanencia

Mr. Kojiro Kinoshita serves as the Chief Executive Officer and Representative Director of Nissan Chemical Corporation since 2008. He serves as Chairman of the Board at of Nissan Chemical Corporation since...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kojiro Kinoshita	CEO & Chairman	16.5yrs	sin datos	0.071% ¥ 485.9m
Shinsuke Yagi	President	3.5yrs	sin datos	0.0080% ¥ 54.5m
Hideki Daimon	Sr. Managing Executive Officer	2.3yrs	sin datos	0.00072% ¥ 4.9m
Hideyuki Endo	Managing Executive Officer	1.5yrs	sin datos	sin datos
Nobutomo Tsuruzoe	Managing Executive Officer and Head of Advanced Materials & Planning Dept.	6.5yrs	sin datos	sin datos
Yuji Nishida	Executive Officer & Plant Manager of Toyama Plant	no data	sin datos	sin datos
Takashi Honda	Senior EVP & Director	7.5yrs	sin datos	0.0051% ¥ 34.7m
Motoaki Ishikawa	Senior Managing Executive Officer	no data	sin datos	0.0043% ¥ 29.7m
Satoshi Kageshima	Executive Officer & Head of Intellectual Property Dept.	1.5yrs	sin datos	sin datos
Takeshi Matsuoka	Managing Executive Officer	5.3yrs	sin datos	0.0022% ¥ 14.9m
Yuji Sato	Senior Managing Executive Officer & Head of Agricultural Chemicals Division	4.3yrs	sin datos	sin datos
Kawashima Wataru	Executive Officer	3.5yrs	sin datos	sin datos

3.9yrs

Permanencia media

61yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 4021 se considera experimentado (4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kojiro Kinoshita	CEO & Chairman	22.5yrs	sin datos	0.071% ¥ 485.9m
Shinsuke Yagi	President	4.1yrs	sin datos	0.0080% ¥ 54.5m
Hideki Daimon	Sr. Managing Executive Officer	2.1yrs	sin datos	0.00072% ¥ 4.9m
Takashi Honda	Senior EVP & Director	7.1yrs	sin datos	0.0051% ¥ 34.7m
Motoaki Ishikawa	Senior Managing Executive Officer	2.1yrs	sin datos	0.0043% ¥ 29.7m
Takeshi Matsuoka	Managing Executive Officer	2.1yrs	sin datos	0.0022% ¥ 14.9m
Hidehito Obayashi	Independent Outside Director	5.1yrs	sin datos	sin datos
Noriyuki Katayama	Outside Auditor	10.1yrs	sin datos	0.00072% ¥ 4.9m
Kazunori Kataoka	Independent Outside Director	4.1yrs	sin datos	sin datos
Kazuhiko Ohrai	Auditor	2.1yrs	sin datos	0.0094% ¥ 64.5m
Nakagawa Miyuki	Independent Outside Director	3.1yrs	sin datos	sin datos
Takeoka Yuko	Independent Outside Director	1.5yrs	sin datos	sin datos

3.6yrs

Permanencia media

60yo

Promedio de edad

Junta con experiencia: La junta directiva de 4021 se considera experimentada (3.5 años de antigüedad promedio).

Nissan Chemical Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Nissan Chemical Corporation to Report Q1, 2025 Results on Aug 09, 2024

Less than half of directors are independent

Nissan Chemical Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024

Price target decreased by 7.4% to JP¥6,401

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Nissan Chemical Corporation to Report Q3, 2024 Results on Feb 09, 2024

Upcoming dividend of JP¥70.00 per share at 2.5% yield

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Nissan Chemical Corporation to Report Q2, 2024 Results on Nov 10, 2023

Nissan Chemical Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation (TSE:4021) announces an Equity Buyback for 1,250,000 shares, representing 0.89% for ¥5,000 million.

Nissan Chemical Corporation to Report Q1, 2024 Results on Aug 10, 2023

Upcoming dividend of JP¥94.00 per share at 2.7% yield

Third quarter 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation to Report Fiscal Year 2023 Results on May 15, 2023

Nissan Chemical Corporation Provides Dividend Guidance for the Year Ending March 31, 2023

Less than half of directors are independent

Second quarter 2023 earnings: EPS misses analyst expectations

Second quarter 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation to Report Q3, 2023 Results on Feb 10, 2023

Nissan Chemical Corporation to Report Q2, 2023 Results on Nov 11, 2022

Upcoming dividend of JP¥70.00 per share

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Nissan Chemical Corporation Revises Dividend Guidance for the Second Quarter Ending September 30, 2022 and Year Ending March 31, 2023

Investor sentiment deteriorated over the past week

Full year 2022 earnings: EPS exceeds analyst expectations

Nissan Chemical Corporation Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2023

Nissan Chemical Corporation to Report Q1, 2023 Results on Aug 08, 2022

Less than half of directors are independent

Upcoming dividend of JP¥68.00 per share

Tokyo District Court Renders Judgment on the Patent Infringement Lawsuit Concerning Edirol Capsules Against Sawai Pharmaceutical Co., Ltd., Nichi- Iko Pharmaceutical Co., Ltd. and Nissan Chemical Corporation

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Nissan Chemical Corporation to Report Q4, 2022 Results on May 13, 2022

Second quarter 2022 earnings released: EPS JP¥52.18 (vs JP¥43.55 in 2Q 2021)

Upcoming dividend of JP¥48.00 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS JP¥61.73 (vs JP¥52.37 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥232 (vs JP¥210 in FY 2020)

Nissan Chemical Corporation Announces Dividend for the Full Year Ended March 31, 2021, Payable on June 28, 2021; Provides Divided Guidance for the Second Quarter Ending March 31, 2022 and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2022

Upcoming dividend of JP¥52.00 per share

New 90-day low: JP¥5,710

Chugai Pharmaceutical Co., Ltd. Refiles Patent Infringement Lawsuit Concerning Edirol Capsules

Earnings beat expectations, revenue disappoints

Third quarter 2021 earnings released: EPS JP¥30.92 (vs JP¥20.64 in 3Q 2020)

Nissan Chemical Corporation to Report Fiscal Year 2021 Results on May 14, 2021

New 90-day high: JP¥6,480

Chugai Pharmaceutical Co., Ltd. Files Patent Infringement Lawsuit Against Nissan Chemical Corporation, Sawai Pharmaceutical Co., Ltd. and Nichi-Iko Pharmaceutical Co., Ltd

Nissan Chemical Corporation to Report Q3, 2021 Results on Feb 05, 2021

Nissan Chemical Corporation to Report Q2, 2021 Results on Nov 12, 2020

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad